Loading
JHX: what insiders have been doing
This page follows insider dealings at JHX as filed with ASX, a company from the Chemicals sector. Between 18 October 2025 and 18 October 2026, 3 insiders published 4 filings.
All open-market trades in the period are sales: 2 sales worth €12.5M, by 1 insider, with no purchase on record. At €7.2M, the sale published on 27 August 2026 by Jesse Singh is the largest of the period (0.054% of market cap).
Filings reach the ASX feed a median of 6 days after the trade. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Across the 2,222 companies tracked on its exchange, the median is 3 filings; at 4 filings, this issuer sits above that mark. Our records for JHX go back to 2026, with no purchases and 2 sales on the open market in total.
In the same sector, recent insider purchases at Culp Inc and Gold.com, Inc. also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€12M
2 ops. · all time
Who traded when
BuySaleJesse Singh2 sales
Analyst consensus: bullish or bearish?
Analysts rate JHX Buy (bullish), based on 17 analysts. Average price target: A$44.96.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,494 of 24,158 companies
33.4
score / 100
Value31
Quality36
FCF yld1.0%
Earn yld0.5%
EV/EBITDA27.7x
ROE3.3%
Gross mgn36%
Net mgn2.2%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
A$36.13
Analyst consensus
17 analystsBuy
A$34.70Target A$44.96(+24%)A$51.18
Income statement
RevenueA$4.8B
Gross profitA$1.7B36% margin
EBITDAA$931.3M19% margin
Net incomeA$104M2.7% margin
Valuation
PER (trailing)116.5x
PER (forward)23.0x
P/Book2.3x
Beta1.04
Balance sheet & cash
Market capA$21B
Total debtA$4.8B
Free Cash FlowA$199.8M
Debt / Equity69%
Profitability & ownership
ROE3.3%
ROA5.2%
% insiders0.1%
% institutions45.5%
Last declaration on 27 August 2026
Declarations4 total
120,000 shares@ A$72.05110.040% mcap42.6% of flowShareASXASX:2924-03127785-2A1692945
221,457 shares@ A$52.97730.054% mcap57.4% of flowShareASXASX:2924-03127784-2A1692944
34,755 sharesShareASXASX:2924-03125279-2A1691568
ShareASXASX:2924-03090341-2A1672175
4 of 4 declarations
About JHX
JHX is a company specializing in the chemicals and materials sector. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
